secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2024-07-18T23:59:59+00:00
Accession:  0001493152-24-028272
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Technologies completes 1-for-10 reverse stock split effective July 17, 2024
--------------------------------------------------------------------------------

- Reverse stock split ratio 1-for-10 approved by board after stockholder authorization at June 20, 2024 annual meeting.
- Certificate of amendment filed with Delaware; effective 5:00 p.m. ET on July 17, 2024.
- Every ten shares combined into one; no fractional shares, one full share issued for any fractional.
- Common stock to trade split-adjusted under symbol SONM from July 18, 2024; new CUSIP 83548F309.
- Stockholders authorized split at ratio range 1:2 to 1:15; board set final ratio at 1:10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224028272/0001493152-24-028272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224028272/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-028272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer